V. Srivatsa of UTI AMC is strategically reducing exposure to financial services within the UTI Large & Mid Cap Fund due to rising valuations. While maintaining a focus on stability and growth, the fund is selectively diversifying into other sectors.
Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth
Laurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by robust growth in its CDMO